What is Considered a High Methylmalonic Acid (MMA) Level?
A serum MMA level above 0.4 μmol/L (400 nmol/L) is considered elevated and confirms vitamin B12 deficiency, while levels between 0.3-0.4 μmol/L (300-400 nmol/L) represent a mildly elevated or indeterminate range that warrants further clinical evaluation 1.
Diagnostic Thresholds Based on Clinical Context
The most recent NICE guideline 1 establishes MMA as a confirmatory test when initial B12 testing yields indeterminate results. The guideline framework uses MMA to resolve diagnostic uncertainty rather than as a standalone marker, but the research literature provides specific cutoff values:
Standard Serum MMA Reference Ranges
- Normal range: <250-300 nmol/L in most populations 2, 3
- Mildly elevated: 300-400 nmol/L (0.3-0.4 μmol/L) 4
- Elevated/High: >400 nmol/L (>0.4 μmol/L) 4
- Severely elevated: >476 nmol/L in elderly populations 5
Age-Adjusted Considerations
Age significantly impacts MMA interpretation - older adults (≥60 years) have 4-fold higher likelihood of elevated MMA independent of B12 status 3. The upper reference limit increases with age:
- Adults: 72-288 nmol/L after vitamin supplementation 5
- Elderly without supplementation: up to 476 nmol/L 5
- Population-based cutoff for mortality risk: ≥250 nmol/L 2
Critical Confounding Factor: Renal Function
Kidney dysfunction is the strongest predictor of elevated MMA after age 3. Patients with serum creatinine ≥130 μmol/L have 12.6-fold increased likelihood of high MMA 3. The newest evidence suggests using eGFR-adjusted MMA (MMA100) provides better diagnostic accuracy than raw MMA values 6.
Practical Interpretation Algorithm
If MMA >400 nmol/L AND normal renal function: Confirms functional B12 deficiency 1, 4
If MMA 300-400 nmol/L: Indeterminate - consider:
- Renal function (calculate eGFR)
- Age (higher thresholds for elderly)
- Clinical symptoms of B12 deficiency
- Repeat testing or treat empirically 1
If MMA >250 nmol/L with normal B12 levels: May indicate mitochondrial dysfunction, oxidative stress, or subclinical deficiency rather than overt B12 deficiency 2, 7
Important Clinical Caveats
Only 16-18% of high MMA cases are attributable to B12 deficiency alone 3. The remaining cases reflect:
- Renal impairment (13.3% attributable risk) 3
- Advanced age (40.5% attributable risk) 3
- Mitochondrial dysfunction 2, 8
- Oxidative stress states 7, 9
Common pitfall: Attributing all elevated MMA to B12 deficiency without considering renal function leads to misdiagnosis 3, 6. Always assess creatinine/eGFR when interpreting MMA results.
Urinary MMA Alternative
For screening in elderly populations with normal renal function, fasting urinary MMA >2 μmol/mmol creatinine has 93% positive predictive value for elevated serum MMA 4. This may be useful when serum testing is unavailable, though it requires overnight fasting and normal kidney function.
Prognostic Significance Beyond B12 Deficiency
MMA ≥250 nmol/L independently predicts all-cause mortality (HR 1.62) and cardiovascular mortality (HR 1.66) even in patients with normal B12 levels 2. This suggests MMA functions as a biomarker of mitochondrial health and oxidative stress beyond its role in B12 metabolism 2, 8, 9.